Cargando…

Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project

BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacle...

Descripción completa

Detalles Bibliográficos
Autores principales: Paidere, Madara, Pavlovska, Jūlija, Rutkovska, Ieva, Ķikute, Dace, Salmane-Kuļikovska, Ieva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044426/
https://www.ncbi.nlm.nih.gov/pubmed/36973735
http://dx.doi.org/10.1186/s40545-023-00551-2
_version_ 1784913355448778752
author Paidere, Madara
Pavlovska, Jūlija
Rutkovska, Ieva
Ķikute, Dace
Salmane-Kuļikovska, Ieva
author_facet Paidere, Madara
Pavlovska, Jūlija
Rutkovska, Ieva
Ķikute, Dace
Salmane-Kuļikovska, Ieva
author_sort Paidere, Madara
collection PubMed
description BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacles, favorable factors, and benefits of this service from the perspective of pharmacists, being one of the key stakeholders. METHODS: Qualitative data were obtained through a semi-structured focus group interview with pharmacists participating in the project. Inductive thematic analysis was performed on transcript to describe potential gains, obstacles, and prerequisites for implementing the MUR service from the pharmacist’s perspective. RESULTS: Lack of payment, cooperation with physicians, problems with patient involvement and insufficiency of competence, were identified as the main barriers to implementation of the MUR service as a pharmacist-led service in community pharmacy. However, there were also contributing factors for MUR service, such as the interest of patients and pharmacists involved in the project, the support from the employer, the benefit for physicians, the improvement of patient health literacy and medication adherence. CONCLUSIONS: Despite the potential obstacles, the findings in Latvia, as well as other countries, show that the MUR service contributes to the benefit of patients, pharmacists and also physicians; therefore, further steps should be taken to eliminate obstacles and gain additional insights to implement the MUR service in Latvia.
format Online
Article
Text
id pubmed-10044426
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100444262023-03-29 Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project Paidere, Madara Pavlovska, Jūlija Rutkovska, Ieva Ķikute, Dace Salmane-Kuļikovska, Ieva J Pharm Policy Pract Research BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacles, favorable factors, and benefits of this service from the perspective of pharmacists, being one of the key stakeholders. METHODS: Qualitative data were obtained through a semi-structured focus group interview with pharmacists participating in the project. Inductive thematic analysis was performed on transcript to describe potential gains, obstacles, and prerequisites for implementing the MUR service from the pharmacist’s perspective. RESULTS: Lack of payment, cooperation with physicians, problems with patient involvement and insufficiency of competence, were identified as the main barriers to implementation of the MUR service as a pharmacist-led service in community pharmacy. However, there were also contributing factors for MUR service, such as the interest of patients and pharmacists involved in the project, the support from the employer, the benefit for physicians, the improvement of patient health literacy and medication adherence. CONCLUSIONS: Despite the potential obstacles, the findings in Latvia, as well as other countries, show that the MUR service contributes to the benefit of patients, pharmacists and also physicians; therefore, further steps should be taken to eliminate obstacles and gain additional insights to implement the MUR service in Latvia. BioMed Central 2023-03-27 /pmc/articles/PMC10044426/ /pubmed/36973735 http://dx.doi.org/10.1186/s40545-023-00551-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Paidere, Madara
Pavlovska, Jūlija
Rutkovska, Ieva
Ķikute, Dace
Salmane-Kuļikovska, Ieva
Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title_full Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title_fullStr Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title_full_unstemmed Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title_short Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
title_sort medication use review: does it have a future and potential in latvia? the opinion of pharmacists after the pilot project
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044426/
https://www.ncbi.nlm.nih.gov/pubmed/36973735
http://dx.doi.org/10.1186/s40545-023-00551-2
work_keys_str_mv AT paideremadara medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject
AT pavlovskajulija medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject
AT rutkovskaieva medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject
AT kikutedace medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject
AT salmanekulikovskaieva medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject